Overview
A reputed veterinary medicines manufacturing company based in Pune is available for acquisition. Operating from a 35,000 sq. ft. self-owned, WHO-GMP approved facility, the unit has been established for over 10 years and is known for producing high-quality specific veterinary formulations. The manufacturing plant comprises two dedicated sections — Oral Liquids and External Preparations — equipped with modern machinery and compliant infrastructure. The company currently operates at 30% of its total production capacity, offering substantial scope for scale-up and diversification. Presently, the business is engaged in contract manufacturing for several leading multinational companies (MNCs) and has recently obtained its WHO license, further enhancing its credibility and market potential.
Owned Pharmaceutical Industry Formulation
Business Details
2010
Year of Establishment
50
No. of Employees
Running Profitable
Current Status of Business
NoBusiness Relocatable
OwnedProperty Type
22 Crs Property Value
Industrial
Property Classification
Describe Property
Factory , land and building and MAchine
Competition / Market
Hardly have any competition in the market.
Products & Services
Non Human Medecines
Growth Potential
Sky is the limit as the company has more then 150 products and currently manufacturing for all top MNCs in the field. There is a scope of coming out in the market with own brand which can further improve the profit margins. The promoter will continue with the company for 2 years as employee and handover everything including the assets and knowledge as all the formulas are developed by the company.
Reason For Sale
Promotor wants to move out of the business due to health concerns and other issues. As he feels he is working for a very long time now and needs to have explore something else
Financial Details
EBITDA :-
1.3 Crs
PAT :-
46 Lacs
Debt :-
12 Crs
How the Acquisition Process Works
- 01Contact SellerContact Seller
- 02Teaser/Information MemorandumTeaser/Information Memorandum
- 03Valuation ReportValuation Report
- 04FinancialsFinancials
- 05Schedule an Advisory MeetingBook Your Consultation
